Form 4 for NRXS Neuraxis, INC
Accepted 2025-07-03 00:00:00 ET · period of report 2025-07-01 · accession 0000937556-25-000098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-07-03 | 2025-07-01 | NRXS | MASIMO CORP | 10% | S - Sale | $2.25 | -821.3K | 0 | -100% | -$1.85M |
| D | 2025-07-03 | 2025-07-01 | NRXS | MASIMO CORP | 10% | C - Cnv Deriv | $0.00 | +289.8K | 289.8K | New | $0 |
| D | 2025-07-03 | 2025-07-01 | NRXS | MASIMO CORP | 10% | M - OptEx | $0.00 | -289.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-01 | S | D | 289,779 | $2.25 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-01 | S | D | 531,548 | $2.25 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2025-07-01 | C | A | 289,779 | $0.00 | 289,779 | D | — | — | |
| 4 | Derivative | Pre-Funded Warrant, Common Stock (Right to Buy) | 2025-07-01 | M | D | 289,779 | $0.00 | 0 | D | $0.00 · — to — | 289,779 Common Stock | (F1) The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.0005 per share of the Issuer's Common Stock. |